176 related articles for article (PubMed ID: 36430923)
1. Loss of
Bridges K; Yao HH; Nicol B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430923
[TBL] [Abstract][Full Text] [Related]
2. RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2.
Nicol B; Grimm SA; Chalmel F; Lecluze E; Pannetier M; Pailhoux E; Dupin-De-Beyssat E; Guiguen Y; Capel B; Yao HH
Nat Commun; 2019 Nov; 10(1):5116. PubMed ID: 31712577
[TBL] [Abstract][Full Text] [Related]
3. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.
Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS
Cancer Res; 2005 Oct; 65(20):9206-15. PubMed ID: 16230381
[TBL] [Abstract][Full Text] [Related]
4. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
5. The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.
Keita M; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Trinh XB; Bachvarov D
Cell Cycle; 2013 Mar; 12(6):972-86. PubMed ID: 23442798
[TBL] [Abstract][Full Text] [Related]
6. Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary.
De Cian MC; Pauper E; Bandiera R; Vidal VP; Sacco S; Gregoire EP; Chassot AA; Panzolini C; Wilhelm D; Pailhoux E; Youssef SA; de Bruin A; Teerds K; Schedl A; Gillot I; Chaboissier MC
Oncogene; 2017 Jan; 36(2):208-218. PubMed ID: 27270435
[TBL] [Abstract][Full Text] [Related]
7. Core Binding Factor-β Knockdown Alters Ovarian Gene Expression and Function in the Mouse.
Wilson K; Park J; Curry TE; Mishra B; Gossen J; Taniuchi I; Jo M
Mol Endocrinol; 2016 Jul; 30(7):733-47. PubMed ID: 27176614
[TBL] [Abstract][Full Text] [Related]
8. Role of activin C in normal ovaries and granulosa cell tumours of mice and humans.
Reader KL; Marino FE; Nicholson HD; Risbridger GP; Gold EJ
Reprod Fertil Dev; 2018 Jun; 30(7):958-968. PubMed ID: 29207252
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis.
Gao Y; Vincent DF; Davis AJ; Sansom OJ; Bartholin L; Li Q
Oncotarget; 2016 Jul; 7(27):40904-40918. PubMed ID: 27344183
[TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles.
Jo M; Curry TE
Mol Endocrinol; 2006 Sep; 20(9):2156-72. PubMed ID: 16675540
[TBL] [Abstract][Full Text] [Related]
11. Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.
Scheitz CJ; Lee TS; McDermitt DJ; Tumbar T
EMBO J; 2012 Nov; 31(21):4124-39. PubMed ID: 23034403
[TBL] [Abstract][Full Text] [Related]
12. Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.
Andreu-Vieyra C; Chen R; Matzuk MM
Mol Endocrinol; 2008 Sep; 22(9):2141-61. PubMed ID: 18599617
[TBL] [Abstract][Full Text] [Related]
13. BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors.
Tripurani SK; Cook RW; Eldin KW; Pangas SA
Oncogene; 2013 Aug; 32(33):3877-85. PubMed ID: 22964636
[TBL] [Abstract][Full Text] [Related]
14. Gene expression in abnormal ovarian structures of ewes homozygous for the inverdale prolificacy gene.
Juengel JL; Quirke LD; Tisdall DJ; Smith P; Hudson NL; McNatty KP
Biol Reprod; 2000 Jun; 62(6):1467-78. PubMed ID: 10819746
[TBL] [Abstract][Full Text] [Related]
15. The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers.
Pitman JL; McNeilly AS; McNeilly JR; Hays LE; Bagby GC; Sawyer HR; McNatty KP
Int J Dev Biol; 2012; 56(10-12):949-58. PubMed ID: 23417416
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Kobayashi H; Wake N; Tsuneyoshi M
Histopathology; 2011 Feb; 58(3):423-32. PubMed ID: 21299609
[TBL] [Abstract][Full Text] [Related]
17. The role for runt related transcription factor 2 (RUNX2) as a transcriptional repressor in luteinizing granulosa cells.
Park ES; Park J; Franceschi RT; Jo M
Mol Cell Endocrinol; 2012 Oct; 362(1-2):165-75. PubMed ID: 22713854
[TBL] [Abstract][Full Text] [Related]
18. Ovarian granulosa cell survival and proliferation requires the gonad-selective TFIID subunit TAF4b.
Voronina E; Lovasco LA; Gyuris A; Baumgartner RA; Parlow AF; Freiman RN
Dev Biol; 2007 Mar; 303(2):715-26. PubMed ID: 17207475
[TBL] [Abstract][Full Text] [Related]
19. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.
Middlebrook BS; Eldin K; Li X; Shivasankaran S; Pangas SA
Endocrinology; 2009 Dec; 150(12):5208-17. PubMed ID: 19819941
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.
Ge T; Yin M; Yang M; Liu T; Lou G
Cell Physiol Biochem; 2014; 34(6):2209-20. PubMed ID: 25562167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
